54 107 Pill - beige round, 10mm
Pill with imprint 54 107 is Beige, Round and has been identified as Lithium Carbonate Extended Release 300 mg. It is supplied by Roxane Laboratories, Inc.
Lithium is used in the treatment of Bipolar Disorder; Schizoaffective Disorder; Mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 107
Lithium Carbonate Extended Release
- Imprint
- 54 107
- Strength
- 300 mg
- Color
- Beige
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roxane Laboratories, Inc.
- Inactive Ingredients
-
calcium stearate,
povidone,
sodium chloride,
sodium lauryl sulfate,
sorbitol,
hypromelloses,
polydextrose,
ferric oxide red,
titanium dioxide,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00054-0021 | Roxane Laboratories, Inc. |
| 68084-0640 | Amerisource Health Services |
More about lithium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (483)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antimanic agents
- Breastfeeding
- En español
Patient resources
- Lithium drug information
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
Other brands
Eskalith, Lithobid, Eskalith-CR
Professional resources
- Lithium monograph
- Lithium (FDA)
- Lithium Capsules (FDA)
- Lithium Carbonate (FDA)
- Lithium Carbonate ER Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
